Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Australia
/
Healthcare
/
Australian Clinical Labs
ACL
Australian Clinical Labs
Regulatory Shifts And Inflation Will Strain Margins With Automation Gains
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
12 Jul 25
Updated
09 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
AU$3.15
10.8% undervalued
intrinsic discount
09 Aug
AU$2.81
Loading
1Y
14.2%
7D
3.7%
Author's Valuation
AU$3.2
10.8% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
AU$3.2
10.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-24m
996m
2017
2019
2021
2023
2025
2027
2028
Revenue AU$859.5m
Earnings AU$51.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.43%
Healthcare Services revenue growth rate
0.29%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.48%
Calculation
AU$51.07m
Earnings '28
x
14.22x
PE Ratio '28
=
AU$726.31m
Market Cap '28
AU$726.31m
Market Cap '28
/
195.84m
No. shares '28
=
AU$3.71
Share Price '28
AU$3.71
Share Price '28
Discounted to 2025 @ 6.48% p.a.
=
AU$3.07
Fair Value '25
